Natural health product · NPN 80092037
Ginger Tablets
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed May 3, 2019; licence last revised October 26, 2024.
- Natural Product Number (NPN)
- 80092037
- Licence holder
- Wampole Group L.P.
- Dosage form
- Tablet
- Route
- Oral
- Licensing route
- CompendialThe company attested that the product meets a Health Canada monograph.
- First licensed
- May 3, 2019
- Licence last revised
- October 26, 2024
Also sold as
Other product names on the same licence.
- Anti-nauseant Tablets
- Comprimés Anti-Nausée
- Gingembre
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| Zingiber officinale | 20 milligrams | Rhizome; 25.0:1.0 Dry; equivalent to 500.0 milligrams dried herb |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Help(s) prevent nausea and vomiting associated with motion sickness, and/or seasickness. Traditionally used in Herbal Medicine as an expectorant and cough suppressant (antitussive) to help relieve bronchitis as well as coughs and colds. Traditionally used in Herbal Medicine to help relieve digestive upset/disturbances including lack of appetite, nausea, digestive spasms, indigestion, dyspepsia and flatulent colic (carminative).
Non-medicinal ingredients
FD&C Yellow No. 5 Aluminum Lake; Hypromellose; Maltodextrin; FD&C Yellow No. 6 Aluminum Lake; Microcrystalline cellulose; Talc; Polydextrose; Titanium dioxide; Silicon dioxide; Macrogol 4000; Croscarmellose sodium; Magnesium stearate; Polyvinyl alcohol